← k3vl4r
Log inGet started →

INDV (Indivior Pharmaceuticals Inc) Price Forecast

AI-generated price forecast for Indivior Pharmaceuticals Inc (INDV) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's AI model currently reads INDV as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 35.71. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

35.71

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏PostTelegram

INDV forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour———
Daily~3 months out▼ Down-27.46%20%
Weekly~1.7 years out▼ Down-46.77%—

Latest INDV news

From the market-news feed the forecasts are read against.

  • Head to Head Survey: Indivior (NASDAQ:INDV) vs. Sonoma Pharmaceuticals (NASDAQ:SNOA) · ldr:themarketsdaily.com · Sep 30
  • 425 Merger Prospectus Thu Sep 17 2026 · ldr:last10k.com · Sep 17
  • 8-K Material Event Thu Sep 17 2026 · ldr:last10k.com · Sep 17
  • Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend · Yahoo · Sep 17
  • 5 Small Drug Stocks Poised to Benefit From a Biotech Recovery · Zacks · Sep 14

🔒

See the full INDV forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

INDV forecast — frequently asked

Will INDV go up?

K3vl4r's AI model currently reads INDV as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the INDV price prediction for 2026?

K3vl4r's model projects INDV toward $35.61 over the next ~3 months, a -0.3% move from $35.71. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could INDV reach?

Over its longest horizon (~~1.7 years), the model's projected target for INDV is $35.54 (-0.5% vs $35.71). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

ZBIOCRMDINDPZVRAQNCXOSURATECPTGXPROKIARTCPHIGRCEEWTXSNN

Will INDV reach…?

Will INDV reach $50.00?Will INDV reach $100.00?Will INDV reach $200.00?Will INDV reach $250.00?

Or see the full INDV price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare INDV

INDV vs ZBIOINDV vs CRMDINDV vs INDPINDV vs ZVRAINDV vs QNCXINDV vs OSUR

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.